Categories: Business

China's Muyuan targets top-end pricing for Hong Kong listing, seeks to raise $1.4 billion

Feb 4 (Reuters) – China's biggest pig breeder, Muyuan Foods said on Wednesday it has determined to price its Hong Kong listing at its maximum offer price, aiming to raise about HK$10.69 billion ($1.37 billion) from the share sale. The firm has offered 274 million H shares for the listing, with the offer price at HK$39 apiece, which sets the share sale to be one of Hong Kong's biggest so far this year. Muyuan Foods expects to announce the allocation results on February 5. The shares will make their debut on the Hong Kong bourse on February 6, according to a regulatory filing. The offering comes as China grapples with a pork glut amid weak demand and a slowing economy, which has pushed prices lower and squeezed farmers' margins. Proceeds from the share sale will be used to fund research and development in areas such as breeding, smart farming, nutrition management and biosecurity. ($1 = 7.8109 Hong Kong dollars) (Reporting by Shivangi Lahiri in Bengaluru; Editing by Eileen Soreng)

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Indianews Syndication

Recent Posts

UPDATE 3-MLB Orioles vs Blue Jays Box Score

Orioles 4, Blue Jays 3 Blue Jays ab r h rbi bb so avg Bateman…

4 minutes ago

Tigers ride 3 home runs to blowout win over Nationals

VIDEO SHOWS: HIGHLIGHTS OF THE MLB GAME BETWEEN THE ATLANTA BRAVES AND THE HOUSTON ASTROS…

5 minutes ago

BRIEF-National Stock Exchange Of India Ltd Fixes IPO Offer Price At 1,785 Rupees Per Share- Prospectus

Sept 22 (Reuters) - National Stock Exchange Of India Ltd : * NATIONAL STOCK EXCHANGE…

8 minutes ago

New Zealand central bank chief sees risks to economy, inflation

SYDNEY, Sept 22 (Reuters) - New Zealand's top central banker said on Tuesday if recent…

10 minutes ago

Nvidia, QIA-backed Iambic Therapeutics files for US IPO as biotech boom rolls on

Sept 21 (Reuters) - Drug developer Iambic Therapeutics, backed by chip giant Nvidia and Qatar's…

11 minutes ago

BRIEF-New World, ADIA In Talks For HK$3 Billion Hotel Sale To UOL- Bloomberg News

Sept 21 (Reuters) - * NEW WORLD, ADIA IN TALKS FOR HK$3 BILLION HOTEL SALE…

15 minutes ago